Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.

<h4>Objective</h4>To examine clinico-pathological factors associated with surgical complications and postoperative therapy for clinical stage IB-IIB cervical cancer.<h4>Methods</h4>This nationwide multicenter retrospective study examined women with clinical stage IB-IIB cervi...

Full description

Bibliographic Details
Main Authors: Hiroko Machida, Koji Matsuo, Akiko Furusawa, Tsunekazu Kita, Ryo Kitagawa, Mikio Mikami
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0210125
_version_ 1818589457168728064
author Hiroko Machida
Koji Matsuo
Akiko Furusawa
Tsunekazu Kita
Ryo Kitagawa
Mikio Mikami
author_facet Hiroko Machida
Koji Matsuo
Akiko Furusawa
Tsunekazu Kita
Ryo Kitagawa
Mikio Mikami
author_sort Hiroko Machida
collection DOAJ
description <h4>Objective</h4>To examine clinico-pathological factors associated with surgical complications and postoperative therapy for clinical stage IB-IIB cervical cancer.<h4>Methods</h4>This nationwide multicenter retrospective study examined women with clinical stage IB-IIB cervical cancer who underwent radical hysterectomy plus pelvic and/or para-aortic lymphadenectomy between 2008-2009 at 87 institutions of the Japanese Gynecologic Oncology Group (n = 693). Multivariate models were used to identify independent predictors of perioperative grade 3-4 complications and bladder dysfunction.<h4>Results</h4>The overall intraoperative and postoperative complication rates were 3.3% and 9.8%, respectively. Clinical stage was not associated with perioperative complications (P = 0.15). Radiotherapy-based adjuvant therapy was significantly associated with an increased risk of postoperative complications (radiotherapy alone: adjusted-odds ratio [OR] 3.19, 95% confidence interval [CI] 1.46-6.99, P = 0.004; radiotherapy plus chemotherapy: adjusted-OR 3.26, 95%CI 1.66-6.41, P = 0.001), whereas chemotherapy was not (P = 0.45). Nerve-sparing surgery significantly reduced the risk of postoperative bladder dysfunction (adjusted-OR 0.57, 95%CI 0.37-0.90, P = 0.02) whereas adjuvant chemotherapy increased the risk of bladder dysfunction (adjusted-OR 2.06, 95%CI 1.16-3.67, P = 0.01). Among women receiving adjuvant chemotherapy, nerve-sparing radical hysterectomy significantly reduced the risk of bladder dysfunction (15.0% versus 32.9%, OR 0.31, 95%CI 0.14-0.68, P = 0.004). After propensity score matching, survival outcomes were similar with both types of adjuvant therapy (radiotherapy-based versus chemotherapy, P>0.05).<h4>Conclusion</h4>Our study highlighted two distinct complication profiles of adjuvant therapy after radical hysterectomy for clinical stage IB-IIB cervical cancer, with radiotherapy increasing grade 3-4 adverse events and chemotherapy increasing bladder dysfunction. In this setting, nerve-sparing surgery may be useful if chemotherapy is being considered for adjuvant therapy.
first_indexed 2024-12-16T09:40:57Z
format Article
id doaj.art-d1407c67eaba4e4c9cc143068f961a6b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T09:40:57Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d1407c67eaba4e4c9cc143068f961a6b2022-12-21T22:36:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01141e021012510.1371/journal.pone.0210125Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.Hiroko MachidaKoji MatsuoAkiko FurusawaTsunekazu KitaRyo KitagawaMikio Mikami<h4>Objective</h4>To examine clinico-pathological factors associated with surgical complications and postoperative therapy for clinical stage IB-IIB cervical cancer.<h4>Methods</h4>This nationwide multicenter retrospective study examined women with clinical stage IB-IIB cervical cancer who underwent radical hysterectomy plus pelvic and/or para-aortic lymphadenectomy between 2008-2009 at 87 institutions of the Japanese Gynecologic Oncology Group (n = 693). Multivariate models were used to identify independent predictors of perioperative grade 3-4 complications and bladder dysfunction.<h4>Results</h4>The overall intraoperative and postoperative complication rates were 3.3% and 9.8%, respectively. Clinical stage was not associated with perioperative complications (P = 0.15). Radiotherapy-based adjuvant therapy was significantly associated with an increased risk of postoperative complications (radiotherapy alone: adjusted-odds ratio [OR] 3.19, 95% confidence interval [CI] 1.46-6.99, P = 0.004; radiotherapy plus chemotherapy: adjusted-OR 3.26, 95%CI 1.66-6.41, P = 0.001), whereas chemotherapy was not (P = 0.45). Nerve-sparing surgery significantly reduced the risk of postoperative bladder dysfunction (adjusted-OR 0.57, 95%CI 0.37-0.90, P = 0.02) whereas adjuvant chemotherapy increased the risk of bladder dysfunction (adjusted-OR 2.06, 95%CI 1.16-3.67, P = 0.01). Among women receiving adjuvant chemotherapy, nerve-sparing radical hysterectomy significantly reduced the risk of bladder dysfunction (15.0% versus 32.9%, OR 0.31, 95%CI 0.14-0.68, P = 0.004). After propensity score matching, survival outcomes were similar with both types of adjuvant therapy (radiotherapy-based versus chemotherapy, P>0.05).<h4>Conclusion</h4>Our study highlighted two distinct complication profiles of adjuvant therapy after radical hysterectomy for clinical stage IB-IIB cervical cancer, with radiotherapy increasing grade 3-4 adverse events and chemotherapy increasing bladder dysfunction. In this setting, nerve-sparing surgery may be useful if chemotherapy is being considered for adjuvant therapy.https://doi.org/10.1371/journal.pone.0210125
spellingShingle Hiroko Machida
Koji Matsuo
Akiko Furusawa
Tsunekazu Kita
Ryo Kitagawa
Mikio Mikami
Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
PLoS ONE
title Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
title_full Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
title_fullStr Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
title_full_unstemmed Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
title_short Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
title_sort profile of treatment related complications in women with clinical stage ib iib cervical cancer a nationwide cohort study in japan
url https://doi.org/10.1371/journal.pone.0210125
work_keys_str_mv AT hirokomachida profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan
AT kojimatsuo profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan
AT akikofurusawa profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan
AT tsunekazukita profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan
AT ryokitagawa profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan
AT mikiomikami profileoftreatmentrelatedcomplicationsinwomenwithclinicalstageibiibcervicalcanceranationwidecohortstudyinjapan